Molecular characterization of the anti-idiotypic immune response of a relapse-free neuroblastoma patient following antibody therapy: a possible vaccine against tumors of neuroectodermal origin?
about
Disialoganglioside directed immunotherapy of neuroblastoma.Treatment of high-risk neuroblastoma with anti-GD2 antibodies.Glycans as targets for therapeutic antitumor antibodies.Immunological and histopathological changes in sheep affected with cutaneous squamous cell carcinoma and treated immunotherapeutically.
P2860
Molecular characterization of the anti-idiotypic immune response of a relapse-free neuroblastoma patient following antibody therapy: a possible vaccine against tumors of neuroectodermal origin?
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Molecular characterization of ...... ors of neuroectodermal origin?
@ast
Molecular characterization of ...... ors of neuroectodermal origin?
@en
type
label
Molecular characterization of ...... ors of neuroectodermal origin?
@ast
Molecular characterization of ...... ors of neuroectodermal origin?
@en
prefLabel
Molecular characterization of ...... ors of neuroectodermal origin?
@ast
Molecular characterization of ...... ors of neuroectodermal origin?
@en
P2093
P1476
Molecular characterization of ...... ors of neuroectodermal origin?
@en
P2093
Jörg A Krüger
Martina M Uttenreuther-Fischer
Peter Fischer
P304
P356
10.4049/JIMMUNOL.176.12.7775
P407
P577
2006-06-01T00:00:00Z